Mind Medicine (MindMed) (MNMD) Competitors $12.47 +0.04 (+0.32%) Closing price 04:00 PM EasternExtended Trading$12.50 +0.03 (+0.25%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock MNMD vs. CRNX, GMTX, LNTH, VKTX, PRAX, MIRM, TLX, ACAD, QURE, and ADMAShould you be buying Mind Medicine (MindMed) stock or one of its competitors? The main competitors of Mind Medicine (MindMed) include Crinetics Pharmaceuticals (CRNX), Gemini Therapeutics (GMTX), Lantheus (LNTH), Viking Therapeutics (VKTX), Praxis Precision Medicines (PRAX), Mirum Pharmaceuticals (MIRM), Telix Pharmaceuticals (TLX), ACADIA Pharmaceuticals (ACAD), uniQure (QURE), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry. Mind Medicine (MindMed) vs. Its Competitors Crinetics Pharmaceuticals Gemini Therapeutics Lantheus Viking Therapeutics Praxis Precision Medicines Mirum Pharmaceuticals Telix Pharmaceuticals ACADIA Pharmaceuticals uniQure ADMA Biologics Crinetics Pharmaceuticals (NASDAQ:CRNX) and Mind Medicine (MindMed) (NASDAQ:MNMD) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability. Do analysts rate CRNX or MNMD? Crinetics Pharmaceuticals currently has a consensus price target of $74.45, indicating a potential upside of 85.76%. Mind Medicine (MindMed) has a consensus price target of $27.83, indicating a potential upside of 123.20%. Given Mind Medicine (MindMed)'s stronger consensus rating and higher possible upside, analysts plainly believe Mind Medicine (MindMed) is more favorable than Crinetics Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Crinetics Pharmaceuticals 1 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.71Mind Medicine (MindMed) 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00 Which has stronger valuation and earnings, CRNX or MNMD? Mind Medicine (MindMed) has lower revenue, but higher earnings than Crinetics Pharmaceuticals. Crinetics Pharmaceuticals is trading at a lower price-to-earnings ratio than Mind Medicine (MindMed), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCrinetics Pharmaceuticals$1.04M3,629.55-$298.41M-$4.11-9.75Mind Medicine (MindMed)N/AN/A-$108.68M-$1.53-8.15 Which has more volatility and risk, CRNX or MNMD? Crinetics Pharmaceuticals has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500. Comparatively, Mind Medicine (MindMed) has a beta of 2.55, meaning that its share price is 155% more volatile than the S&P 500. Is CRNX or MNMD more profitable? Crinetics Pharmaceuticals' return on equity of -32.28% beat Mind Medicine (MindMed)'s return on equity.Company Net Margins Return on Equity Return on Assets Crinetics PharmaceuticalsN/A -32.28% -29.45% Mind Medicine (MindMed) N/A -50.24%-39.41% Do institutionals and insiders believe in CRNX or MNMD? 98.5% of Crinetics Pharmaceuticals shares are held by institutional investors. Comparatively, 27.9% of Mind Medicine (MindMed) shares are held by institutional investors. 4.6% of Crinetics Pharmaceuticals shares are held by company insiders. Comparatively, 2.5% of Mind Medicine (MindMed) shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media refer more to CRNX or MNMD? In the previous week, Mind Medicine (MindMed) had 1 more articles in the media than Crinetics Pharmaceuticals. MarketBeat recorded 5 mentions for Mind Medicine (MindMed) and 4 mentions for Crinetics Pharmaceuticals. Crinetics Pharmaceuticals' average media sentiment score of 1.84 beat Mind Medicine (MindMed)'s score of 0.91 indicating that Crinetics Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Crinetics Pharmaceuticals 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Mind Medicine (MindMed) 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMind Medicine (MindMed) beats Crinetics Pharmaceuticals on 8 of the 15 factors compared between the two stocks. Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MNMD vs. The Competition Export to ExcelMetricMind Medicine (MindMed)MED IndustryMedical SectorNASDAQ ExchangeMarket Cap$945.77M$3.44B$6.19B$10.60BDividend YieldN/A2.26%5.72%4.86%P/E Ratio-8.158.2221.1124.06Price / SalesN/A477.59577.46128.87Price / CashN/A44.5736.5560.64Price / Book3.8810.3512.076.53Net Income-$108.68M-$52.53M$3.32B$276.75M7 Day Performance4.70%-0.22%-0.16%0.20%1 Month Performance25.33%10.89%5.76%1.67%1 Year Performance100.48%14.19%65.71%32.73% Mind Medicine (MindMed) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MNMDMind Medicine (MindMed)3.4248 of 5 stars$12.47+0.3%$27.83+123.2%+97.0%$945.77MN/A-8.1540CRNXCrinetics Pharmaceuticals4.333 of 5 stars$42.45+2.1%$74.45+75.4%-32.2%$4.00B$1.04M-10.33210GMTXGemini TherapeuticsN/A$89.94+21.0%N/A+69.2%$3.90BN/A-89.9430High Trading VolumeLNTHLantheus4.5894 of 5 stars$56.60+1.8%$74.50+31.6%-49.3%$3.85B$1.53B15.05700Trending NewsVKTXViking Therapeutics3.9731 of 5 stars$33.75+0.7%$86.42+156.0%-49.3%$3.79BN/A-22.0620News CoverageEarnings ReportAnalyst DowngradeGap UpPRAXPraxis Precision Medicines2.4873 of 5 stars$175.07-7.9%$222.36+27.0%+155.3%$3.71B$8.55M-14.24110Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading VolumeMIRMMirum Pharmaceuticals3.8919 of 5 stars$73.03-0.7%$79.70+9.1%+75.4%$3.67B$336.89M-60.35140TLXTelix Pharmaceuticals3.8325 of 5 stars$10.79-0.1%$21.00+94.6%N/A$3.65B$637.77M0.00N/ANews CoverageACADACADIA Pharmaceuticals3.9087 of 5 stars$20.94+0.2%$29.12+39.1%+47.3%$3.53B$957.80M15.74510Analyst ForecastQUREuniQure2.6033 of 5 stars$63.92+10.2%$71.75+12.2%+800.9%$3.51B$27.12M-16.31500ADMAADMA Biologics3.6858 of 5 stars$14.69+2.3%$27.67+88.3%-3.3%$3.51B$426.45M17.08530Positive News Related Companies and Tools Related Companies CRNX Alternatives GMTX Alternatives LNTH Alternatives VKTX Alternatives PRAX Alternatives MIRM Alternatives TLX Alternatives ACAD Alternatives QURE Alternatives ADMA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MNMD) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | Sponsored7 market signals flashing red right nowRight now, the same 7 key indicators that predicted 1929, the 1970s stagflation, and the 2008 meltdown are all...American Alternative | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNMD Stock Alerts